Longevity One » Omaveloxolone functions as a molecular crowbar-like degrader of STING to alleviate aging-related inflammation
Contributor+

Omaveloxolone functions as a molecular crowbar-like degrader of STING to alleviate aging-related inflammation

September 18, 2026
4 min read
Email
Facebook
X
LinkedIn
Print
On this page
  1. Acknowledgements
  2. Funding
  3. Author information
  4. Authors and Affiliations
  5. Corresponding authors
  6. Ethics declarations
  7. Competing interests
  8. Additional information
  9. Supplementary information
  10. Source data
  11. Rights and permissions
  12. About this article
  13. Cite this article

Acknowledgements

We thank the staff members of the Large-scale Protein Preparation System at the National Facility for Protein Science in Shanghai (NFPS), Shanghai Advanced Research Institute, Chinese Academy of Science, China, for providing technical support and assistance in data collection and analysis. We thank the Institutional Technology Service Center of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, for technical assistance in mass spectrometry experiments and analysis.

Funding

This work was supported by the following grants: the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB0830200, XDB1260301), National Natural Science Foundation of China (T2225002 and 82273855 to M.Z., 82474143 to S.Z., 82404513 D.T.), National Key Research and Development Program of China (2023YFC2305904 and 2022YFC3400504 to M.Z.), the Youth Innovation Promotion Association CAS (2023296 to S.Z.), Young Elite Scientists Sponsorship Program by CAST (2023QNRC001 to S.Z.), Postdoctoral Fellowship Program of CPSF (GZC20232846 to D.T.), China Postdoctoral Science Foundation (2024M763419 to D.T.).

Author information

Author notes

  1. These authors contributed equally: Jingyi Zhou, Xinyi Ma, Bing Jiang, Zisheng Fan.

Authors and Affiliations

  1. School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China

    Jingyi Zhou, Penghua Li, Qi Dai, Yajie Wang, Ning Ma, Ruirui Yang, Haiwei Shen, Zhiming Ge, Jiusheng Lin, Mingyue Zheng & Sulin Zhang

  2. Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

    Jingyi Zhou, Bing Jiang, Zisheng Fan, Qi Dai, Yajie Wang, Min Wu, Ning Ma, Manlin Huang, Zhiming Ge, Dan Teng, Mingyue Zheng & Sulin Zhang

  3. School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China

    Xinyi Ma, Bing Jiang, Jingyi Meng & Mingyue Zheng

  4. Department of Translational Medicine Platform, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China

    Penghua Li

  5. University of Chinese Academy of Sciences, Beijing, China

    Qi Dai, Yajie Wang, Ning Ma, Ruirui Yang, Haiwei Shen, Zhiming Ge, Jiusheng Lin, Dan Teng, Mingyue Zheng & Sulin Zhang

  6. School of Pharmacy, Nanchang University, Nanchang, China

    Min Wu, Manlin Huang & Mingyue Zheng

  7. Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China

    Qibang Sui

Authors

  1. Jingyi Zhou
  2. Xinyi Ma
  3. Bing Jiang
  4. Zisheng Fan
  5. Penghua Li
  6. Qi Dai
  7. Yajie Wang
  8. Min Wu
  9. Qibang Sui
  10. Ning Ma
  11. Ruirui Yang
  12. Haiwei Shen
  13. Jingyi Meng
  14. Manlin Huang
  15. Zhiming Ge
  16. Jiusheng Lin
  17. Dan Teng
  18. Mingyue Zheng
  19. Sulin Zhang

Corresponding authors

Correspondence to Dan Teng, Mingyue Zheng or Sulin Zhang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Source data

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, J., Ma, X., Jiang, B. et al. Omaveloxolone functions as a molecular crowbar-like degrader of STING to alleviate aging-related inflammation. Nat Commun (2026). https://doi.org/10.1038/s41467-026-77760-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41467-026-77760-1

More from LongevityOne